1.
The nursing experience of rituximab in combined with chemotherapy in elderly patient with non-hodgkin s lymphoma;
利妥昔单抗治疗老年非霍奇金淋巴瘤护理体会
2.
Treatment of B-cell Lymphoma with the Regimen of Rituximab Combined Chemotherapy
利妥昔单抗联合化疗方案治疗B细胞淋巴瘤
3.
Systematic Review of Maintenance Rituximab Therapy in B Cell Non-Hodgkin Lymphoma
利妥昔单抗维持治疗B细胞非霍奇金淋巴瘤的系统评价
4.
Clinic observation with diffuse large B-cell lymphoma treated by combination of rituximab and CHOP
利妥昔单抗联合CHOP方案治疗弥漫性大B细胞淋巴瘤临床观察
5.
Efficacy of rituximab in patients with refractory severe systemic lupus erythematosus
利妥昔单抗治疗难治性重症系统性红斑狼疮的临床初步观察
6.
Treatment of Immunorelated pancytopenia with regimen of rituximab and chemotherapy:a case report
利妥昔单抗联合化疗治疗免疫相关性全血细胞减少症1例
7.
Rituximab therapy for rheumatoid arthritis
利妥昔单抗治疗类风湿性关节炎基础研究临床应用现状及展望
8.
Clinical observation of effect of rituximab combined with chemotherapy on non-Hodgkin's lymphoma
利妥昔单抗联合化疗治疗非霍奇金淋巴瘤的临床观察
9.
Use of Rituximab in Infant Childhood Immune Thrombocytopenic Purpura Who Useless with Routine Treatment
利妥昔单抗治疗婴幼儿常规治疗无效的特发性血小板减少性紫癜
10.
Clinical observation on rituximab combined with chemotherapy in the treatment of diffused large B cell lymphoma
利妥昔单抗联合化疗治疗弥漫型大B细胞淋巴瘤的临床观察
11.
First biotechnology product approved by FDA to treat patients with cancer- a monoclonal antibody called rituximab, used to treat one type of lymphoma.
FDA批准首个治疗癌症的生物技术药物-一种称为利妥昔的单克隆抗体治疗一种淋巴瘤.
12.
Rituximab combination with CHOP treated primary breast non-Hodgkin lymphoma:one case report and leterature review
利妥昔单抗联合CHOP方案治疗原发性乳腺非霍奇金淋巴瘤1例并文献复习
13.
Nursing Care for Patients with B-Cell Non-Hodgkin's Lymphoma Treated with Allogeneic Hematopoietic Stem Cell Transplantation Combined with Rituximab
2例B细胞非霍奇金淋巴瘤患者异基因造血干细胞移植联合利妥昔单抗治疗的护理
14.
A Clinical Study of Rituximab Combined with CHOP in Treatment of B Cell Non-Hodgkins Lymphoma
利妥昔单抗联合CHOP治疗弥漫大B细胞性非霍奇金淋巴瘤的临床观察
15.
Bacterial Endotoxin Test of Cetuximab Injection
西妥昔单抗注射液细菌内毒素检查法
16.
A experimental study on inhibiting effect of cetuximab on angiogenesis
西妥昔单抗抑制血管生成的实验研究
17.
Cetuximab plus chemotherapy in the treatment of patients with head and neck squamous cell carcinomas (HNSCC)
西妥昔单抗联合化疗治疗头颈部鳞癌初步研究
18.
Protection of ward of liver cancer patients after undergoing ~(131)I rituximab intervention therapy
~(131)碘美妥昔单抗介入治疗肝癌术后病室的防护